Earnings Feed
Start Free
Aurinia Pharmaceuticals Inc.·4

May 23, 5:19 PM ET

Jayne David R.W. 4

4 · Aurinia Pharmaceuticals Inc. · Filed May 23, 2023

Insider Transaction Report

Form 4
Period: 2023-05-18
Aurinia Pharmaceuticals Inc.AUPH
Jayne David R.W.
Director
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2023-05-18+8,733→ 48,733 total
  • Award

    Common Stock

    [F2]
    2023-05-19+9,310→ 58,043 total
  • Sale

    Common Stock

    2023-05-23$11.26/sh−8,733$98,334→ 49,310 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1]
    2023-05-18−8,733→ 0 total
    From: 2023-05-18→ Common Stock (8,733 underlying)
  • Award

    Stock Option (right to buy)

    [F3]
    2023-05-19+15,234→ 15,234 total
    Exercise: $10.74Exp: 2033-05-19→ Common Stock (15,234 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
  • [F2]Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
  • [F3]The option vests in twelve equal monthly installments commencing on June 19, 2023.
Signature
/s/ David R.W. Jayne, M.D.|2023-05-23

Documents

1 file
  • 4
    wk-form4_1684876777.xmlPrimary

    FORM 4